Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The compa…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-06-02
Interim MD&A - English.pdf
Results 2026-06-02
Interim financial statements/report – English.pdf
News 2026-04-14
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma
News release - English.pdf
Transactions 2026-03-18 Financing
Telo Genomics Corp. Closes Second and Final Tranche of Convertible Debentures Financing
Material change report - English.pdf
News 2026-03-17
Report of exempt distribution (45-106F1).pdf
Transactions 2026-03-09 Financing
Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing
News release - English.pdf
Results 2026-03-02 Financials
Interim MD&A - English.pdf
Results 2026-03-02 Financials
Interim financial statements/report – English.pdf
Transactions 2026-02-27 Financing
Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement
News release - English.pdf
News 2026-02-26
Report of exempt distribution (45-106F1).pdf
Transactions 2026-02-19 Financing
Telo Genomics Closes First Tranche of Convertible Debentures Financing
News release - English.pdf
Transactions 2026-01-19 Financing
Telo Genomics Announces Non-Brokered Private Placement of Convertible Debentures for up to $1,200,000
News release - English.pdf
News 2025-12-18
Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program
News release - English.pdf
News 2025-12-11
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting
News release - English.pdf
Results 2025-11-25 Financials
Interim MD&A - English.pdf
Results 2025-11-25 Financials
Interim financial statements/report – English.pdf
News 2025-11-13
News release - English.pdf
News 2025-11-10
Other.pdf
News 2025-11-10
Other.pdf
Results 2025-10-27 Financials
Annual MD&A - English.pdf
Results 2025-10-27 Financials
Audited annual financial statements – English.pdf
News 2025-10-17
Material change report - English.pdf
News 2025-10-09
News release - English.pdf
News 2025-09-30
News release - English.pdf
News 2025-09-19
News release - English.pdf
News 2025-09-08
News release - English.pdf
News 2025-08-05
News release - English.pdf
News 2025-07-24
News release - English.pdf
News 2025-07-22
Report of exempt distribution (45-106F1).pdf
News 2025-06-30
News release - English.pdf
News 2025-06-18
News release - English.pdf